Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-3207-2024Class I

Percussionaire, Inc., REF: P5-TEE, Qty: 1, Rx Only. IPV (Intrapulmonary Percussive Ventilation) therapy...

Percussionaire Corp. / initiated 2024-08-21 / Open, Classified / root cause: design

Percussionaire Corporation began a recall of Percussionaire, Inc., REF: P5-TEE, Qty: 1, Rx Only. IPV (Intrapulmonary Percussive Ventilation) therapy In-Line Valve on . FDA classified it as Class I and gives the reason as "Updated labeling to ensure that blue cap on in-line valve is removed, prior to delivery of (Intrapulmonary percussive ventilation) IPV therapy". As of , the recall status on record is Open, Classified, and MDM tags the root cause as design.

Recall record

Recall number
Z-3207-2024
Classification
Class I
Status
Open, Classified
Initiated
Posted
Recalling firm
Percussionaire Corp.
Product
Percussionaire, Inc., REF: P5-TEE, Qty: 1, Rx Only. IPV (Intrapulmonary Percussive Ventilation) therapy In-Line Valve
Product code
BZO Set, Tubing And Support, Ventilator (W Harness)
Reason for recall
Updated labeling to ensure that blue cap on in-line valve is removed, prior to delivery of (Intrapulmonary percussive ventilation) IPV therapy.
Root cause tag
design
FDA root cause
Device Design
Action
On September 3, 2024, Percussionaire Inc. issued a "Urgent Medical Device Field Safety Notice" to affected consignees. Percussionaire asked consignees to take the following actions: 1. Complete and Return Acknowledgement form (see Appendix 1) after reviewing and implementing the requested actions below by September 27, 2024. 2. Review updated instructions for proper in-line use (see Appendix 3) and updated IFU (see Appendix 4) 3. Print and post updated instructions for proper In-Line Valve use (Appendix 3) throughout your facility for adequate distribution of new information to users. 4. Communicate and train with newly presented instructions for proper use to primary users of IPV therapy, specifically for in-line use. 5. Review institutional protocols related to P5-TEE inline use and update as needed to conform with the updated instructions. 6. Re-label current product by placing the sticker provided by Percussionaire on each individual P5-TEE bag on stock (stickers to be provided via mail). 7. Report any adverse events to [email protected] and/or to the FDA s MedWatch Adverse Event Reporting program either online, by regular mail or by fax. 8. Report any quality problems experienced with the use of this product to Percussionaire/Sentec Customer Service department via email to [email protected].
Quantity in commerce
50,460 units
Distribution
US: Nationwide OUS: Israel Japan Russia Switzerland Canada Turkey
Product codes and lots
No UDI/ Lots: 240620, 240610, 240418, 240326, 230612, WO07066, WO07010, WO06020, WO05019, WO04884, WO04827, WO04756, WO04714, WO04656, WO04625, WO04596, WO04553, WO04398, WO04356, WO04061, WO03846, WO03748, WO03688

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-3207-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-3207-2024Class IOngoingVoluntary: Firm initiated
Z-3208-2024Class IOngoingVoluntary: Firm initiated